page_banner

Products

SuplatastTosilate CAS:94055-76-2

Short Description:

Catalog Number: XD96147
Cas: 94055-76-2
Molecular Formula: C23H33NO7S2
Molecular Weight: 499.64062
Availability: In Stock 
Price:  
Prepack:  
Bulk Pack: Request Quote

 


Product Detail

Product Tags

Catalog Number XD96147
Product Name SuplatastTosilate
CAS 94055-76-2
Molecular Formula C23H33NO7S2
Molecular Weight 499.64062
Storage Details Ambient

 

Product Specification

Appearance White powder
Assay 99% min

 

Suplatast tosilate is a pharmaceutical drug that is used primarily as an immunomodulator. It is an active component of an oral tablet formulation and is known to have various effects on the immune system and inflammation. Here, we will delve into the effects and potential uses of suplatast tosilate.Suplatast tosilate acts as an immunomodulatory agent, meaning it helps regulate the functioning of the immune system. It is known to inhibit the production of certain inflammatory cytokines, such as interleukin-4 (IL-4) and interleukin-5 (IL-5). By reducing the production of these cytokines, suplatast tosilate can help alleviate the symptoms of various immune-mediated diseases, such as asthma, allergic rhinitis, and inflammatory bowel disease.In clinical studies, suplatast tosilate has shown efficacy in reducing the severity and frequency of asthma attacks. It has been found to inhibit airway inflammation and improve lung function in patients with bronchial asthma. By modulating the immune response in the airway, suplatast tosilate helps alleviate symptoms like wheezing, coughing, and shortness of breath.The immunomodulatory effects of suplatast tosilate have also been explored in the treatment of allergic rhinitis, a common allergic disorder characterized by inflammation of the nasal passages. It has been shown to reduce the levels of inflammatory markers and improve the symptoms of allergic rhinitis, including nasal congestion, sneezing, and itching.Furthermore, suplatast tosilate has demonstrated potential in treating inflammatory bowel diseases like ulcerative colitis and Crohn's disease. These conditions involve chronic inflammation of the gastrointestinal tract. Suplatast tosilate has been reported to reduce the production of pro-inflammatory cytokines, leading to improved symptoms and disease management.While the primary application of suplatast tosilate lies in its immunomodulatory effects, there is ongoing research exploring its potential in other areas. For example, it has been studied as a potential therapy for certain autoimmune diseases, such as multiple sclerosis and rheumatoid arthritis. Additionally, suplatast tosilate has been investigated for its antioxidant and neuroprotective properties, suggesting potential applications in neurological disorders.It's important to note that suplatast tosilate should only be used under the guidance and prescription of a healthcare professional. Like any medication, it may have potential side effects and interactions with other drugs. Therefore, it's crucial to follow the recommended dosage and inform your doctor about any existing medical conditions or medications you are taking.In summary, suplatast tosilate is an immunomodulatory drug that has shown efficacy in managing immune-mediated diseases such as asthma, allergic rhinitis, and inflammatory bowel disease. Its ability to modulate the immune response and reduce inflammation makes it a valuable therapeutic option in these conditions. Continued research is essential to explore its potential in other areas and further understand its mechanisms of action.


  • Previous:
  • Next:

  • Close

    SuplatastTosilate CAS:94055-76-2